Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia - Concepedia

Concepedia

Publication | Open Access

Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia

DOI Full Paper Access

247

Citations

11

References

2011

Year

Guillermo Garcia‐Manero, Steven D. Gore, Christopher R. Cogle, Renee Ward, Tao Shi, Kyle J. MacBeth, Eric Laille, Heidi Giordano, Sarah Sakoian, Elias Jabbour,

Journal of Clinical Oncology

Abstract

Oral azacitidine was bioavailable and demonstrated biologic and clinical activity in patients with MDSs and CMML.

References

	Year	Citations

Page 1